vancomycin has been researched along with Graft vs Host Disease in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Clouston, AD; Degli-Esposti, MA; Dey, N; Ensbey, KS; Fiedler, TL; Fredricks, DN; Grady, WM; Hattangady, N; Hill, GR; Hippe, DS; Hoffman, NG; Kowalsky, J; Koyama, M; Li, N; Markey, KA; Miltiadous, O; Minnie, SA; Proll, SC; Randolph, TW; Schmidt, CR; Srinivasan, S; Strenk, SM; van den Brink, MRM; Varelias, A; Yeh, AC; Zhang, P | 1 |
Ber Ce, P; Bhasin, B; Chhabra, S; D'Souza, A; Szabo, A | 1 |
Abhyankar, S; Clough, L; Ganguly, S; Grauer, D; Lin, T; Mahmoudjafari, Z; McGuirk, J; Prohaska, L; Shune, L; Singh, A | 1 |
Babushok, DV; Frey, NV; Freyer, CW; Ganetsky, A; Gill, SI; Gilmar, C; Han, JH; Hexner, EO; Hughes, ME; Loren, AW; Luger, SM; Mangan, JK; Martin, ME; Porter, DL; Schuster, M; Smith, J; Stadtmauer, EA | 1 |
Matsue, K; Nishida, Y; Sugihara, H; Takeuchi, M; Ugai, T; Yamakura, M | 1 |
Hohlweg-Majert, B; Kesting, MR; Koulocheris, P; Metzger, MC | 1 |
DePestel, DD; Frame, DG; Kaul, DR; Khaled, Y; Pogue, JM | 1 |
de Magalhaes Silverman, M; Gingrich, RD; Wudhikarn, K | 1 |
Mehta, J; Pi, J; Trifilio, SM | 1 |
Avalos, B; Biggs, J; Brodsky, I; Copelan, E; Crilley, P; Downs, K; Marks, DI; Moul, J; Penza, S; Sabol, P; Styler, MJ; Szer, J; Topolsky, D | 1 |
2 review(s) available for vancomycin and Graft vs Host Disease
Article | Year |
---|---|
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.
Topics: Anti-Bacterial Agents; Bacteremia; Colitis; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Iowa; Opportunistic Infections; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2013 |
Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Aztreonam; Chicago; Ciprofloxacin; Clostridioides difficile; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Risk Factors; Survival Rate; Transplantation, Homologous; Vancomycin; Vancomycin Resistance | 2013 |
8 other study(ies) available for vancomycin and Graft vs Host Disease
Article | Year |
---|---|
Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity.
Topics: Animals; Gastrointestinal Microbiome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Mice; Transplantation, Homologous; Vancomycin | 2023 |
Correlates and Outcomes of Early Acute Kidney Injury after Hematopoietic Cell Transplantation.
Topics: Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Aged; Anti-Bacterial Agents; Case-Control Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2021 |
Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Allografts; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Time Factors; Vancomycin | 2018 |
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Topics: Administration, Oral; Adult; Aged; Antibiotic Prophylaxis; Clostridioides difficile; Clostridium Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hypersensitivity; Male; Middle Aged; Prognosis; Retrospective Studies; Time-to-Treatment; Transplant Recipients; Transplantation, Homologous; Vancomycin; Young Adult | 2019 |
Capnocytophaga canimorsus sepsis following BMT in a patient with AML: possible association with functional asplenia.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow Transplantation; Capnocytophaga; Disease Progression; Dog Diseases; Dogs; Female; Graft vs Host Disease; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Meropenem; Middle Aged; Postoperative Complications; Saliva; Sepsis; Spleen; Thienamycins; Thrombocytosis; Treatment Outcome; Vancomycin | 2014 |
Life-threatening complications associated with acute monocytic leukaemia after dental treatment.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Blast Crisis; Enterobacter cloacae; Enterobacteriaceae Infections; Fatal Outcome; Graft vs Host Disease; Humans; Jaw Diseases; Leukemia, Monocytic, Acute; Male; Osteonecrosis; Sepsis; Stem Cell Transplantation; Tooth Extraction; Vancomycin; Vancomycin Resistance | 2009 |
Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Gastrointestinal Diseases; Gastrointestinal Tract; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intestinal Absorption; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Vancomycin | 2009 |
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Ciprofloxacin; Cyclophosphamide; Estrogens; Female; Genetic Diseases, Inborn; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Life Tables; Liver Diseases; Liver Function Tests; Male; Methotrexate; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Neoplasms; Progestins; Retrospective Studies; Risk Factors; Transplantation Conditioning; Vancomycin | 1996 |